NASDAQ
E-therapeutics Plc (ETXPF) has a eps (diluted) of $-0.02 as of Friday, January 31, 2025. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.